What is Percutaneous Coronary Intervention (PCI)?
Percutaneous coronary intervention (PCI) is a catheter-based procedure that encompasses balloon angioplasty, intracoronary stenting, and other percutaneous techniques (atherectomy, thrombectomy, laser angioplasty) used to relieve coronary artery narrowing and restore blood flow to ischemic myocardium. 1, 2, 3
Core Definition and Terminology
- PCI is the modern umbrella term that replaced the older designation "PTCA" (percutaneous transluminal coronary angioplasty), which referred specifically to balloon angioplasty alone 1, 4
- The ACC/AHA guidelines formally adopted "PCI" to reflect the evolution beyond simple balloon dilation to include stenting and atheroablative technologies 1, 2
- The procedure is performed by introducing a catheter system through a systemic artery under local anesthesia into the stenotic coronary artery, where controlled inflation of a distensible balloon or deployment of a stent relieves the obstruction 5
Components of Modern PCI
The procedure includes multiple technical approaches:
- Standard balloon angioplasty (PTCA) - the foundational technique using balloon inflation to dilate narrowed arteries 1, 3, 4
- Intracoronary stent implantation - now used in 80-85% of PCI procedures in the United States, dramatically reducing acute vessel closure and restenosis rates compared to balloon-only techniques 2, 3
- Drug-eluting stents (DES) - which markedly reduce restenosis risk compared to bare-metal stents 1, 2, 3
- Atheroablative technologies including rotational atherectomy, directional atherectomy, extraction atherectomy, and laser angioplasty 1, 2, 4
- Thrombectomy devices - used in specific lesion subsets, though clinical outcome benefits remain less established 2, 3
Procedural Timing Definition
- PCI procedure start time is defined as when local anesthetic is first administered for vascular access, or the time of first vascular access attempt, whichever occurs earlier 6
- Any attempt to treat a stenosis by any technique—even failed attempts to cross the stenosis with a wire or device—counts as PCI 6
Primary Clinical Applications
PCI serves two fundamental purposes:
Symptom Relief
- The primary benefit in stable coronary artery disease is relief of angina symptoms, not survival improvement in most patients 7
- PCI provides more angina relief than placebo procedures in patients with stable angina and evidence of ischemia on minimal antianginal therapy 8
Prognostic Benefit in Specific Populations
- Primary PCI is the recommended revascularization strategy for ST-elevation myocardial infarction (STEMI), with goal door-to-balloon time within 90 minutes 1, 9
- Early invasive strategy with PCI improves outcomes in high-risk unstable angina/non-ST-elevation MI patients with recurrent ischemia, dynamic ST changes, elevated troponins, or hemodynamic instability 1, 7
- Revascularization may improve survival in left main disease >50%, three-vessel disease (especially with reduced ejection fraction), and proximal LAD disease with extensive ischemia 7
Adjunctive Pharmacological Advances
Modern PCI success depends heavily on pharmacological support:
- Glycoprotein IIb/IIIa receptor antagonists reduce procedure-related myocardial infarctions from approximately 10% to 5% 10, 2
- Dual antiplatelet therapy with thienopyridines (clopidogrel, prasugrel, ticagrelor) is essential for preventing stent thrombosis 1, 2
- Bivalirudin provides alternative anticoagulation during PCI 1, 4
Operator and Facility Requirements
- Operators must perform a minimum of 50 PCIs per year at hospitals performing at least 200 PCIs annually to maintain competency, according to 2013 ACC/AHA/SCAI standards (relaxed from prior 75 PCIs/operator at centers with >400 PCIs/year) 11
- The guidelines assume operators possess both cognitive and technical skills for PCI and that appropriate facilities and resources are available 1, 4
Intravascular Imaging Guidance
- Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) provide superior vessel and plaque characterization compared to angiography alone, optimizing lesion preparation, stent sizing, and deployment 12
- Despite proven benefits, intravascular imaging is currently used in <15% of PCI procedures, representing a significant practice gap 12
Common Procedural Complications
- Approximately 30% of patients undergoing elective PCI sustain some degree of peri-procedural myocardial injury, detectable by sensitive biomarkers (CK-MB, troponin) or cardiac MRI 13
- Historical complications of balloon angioplasty included acute vessel closure (5%) and restenosis (35-45% at 6 months), both dramatically reduced by stenting 3
Critical Clinical Caveats
- PCI should not be performed without objective evidence of ischemia on noninvasive testing in stable patients—this is a Class III (harm) recommendation 14, 7
- For diabetic patients with multivessel disease, CABG provides superior survival compared to PCI (5-year survival 80.6% vs 65.5%, p=0.0003 in BARI trial) 7
- Significant left main disease (>50% stenosis) in CABG-eligible patients is a contraindication to PCI 1, 14